Grants and Contributions:
Title:
Germany-ZIM - MS Patient Gait Monitoring - AI Classifiers and Real World Gait Sensors for MS Patient Monitoring
Agreement Number:
1019330
Agreement Value:
$382,000.00
Agreement Date:
May 1, 2024 - Jun 30, 2026
Description:
“As part of the international consortium project “[MS Patient Gait Monitoring]”, this project will focus on AI-based Digital Biomarker for the Objective Measurement of Gait in Multiple Sclerosis (MS) Patients.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K2K 0G7
Reference Number:
172-2024-2025-Q1-1019330
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
716041942
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 70,000 dollars.
Amendment Date
Dec 16, 2025
Recipient's Operating Name:
Celestra Health Systems
Recipient's Legal Name:
Celestra Health Systems Corporation
Federal Riding Name:
Kanata--Carleton
Federal Riding Number:
35041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911
Amendments: